INHIBITORS OF THE FIBRINOLYTIC ENZYME-SYSTEM

被引：146

作者：

AOKI, N

HARPEL, PC

机构：

[1] JICHI MED SCH,DEPT MED,MINAMIKAWACHI,TOCHIGI 32904,JAPAN

[2] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,DIV HEMATOL ONCOL,NEW YORK,NY 10021

[3] CORNELL UNIV,MED CTR,COLL MED,SPECIALIZED CTR RES THROMBOSIS,NEW YORK,NY 10021

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1984年 / 10卷 / 01期

关键词：

D O I：

10.1055/s-2007-1004405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：24 / 41

页数：18

共 149 条

[91]

NACHMAN RL, 1976, J BIOL CHEM, V251, P4514

[92] ASSAY OF ALPHA-2-PLASMIN INHIBITOR ACTIVITY BY MEANS OF A PLASMIN SPECIFIC TRIPEPTIDE SUBSTRATE [J].

NAITO, K ;

AOKI, N .

THROMBOSIS RESEARCH, 1978, 12 (06) :1147-1156

[93] PLASMIN PLASMIN INHIBITORS AND DEGRADATION PRODUCTS OF FIBRINOGEN IN HUMAN SERUM DURING AND AFTER INTRAVENOUS INFUSION OF STREPTOKINASE [J].

NILEHN, JE ;

GANROT, PO .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1967, 20 (02) :113-&

[94] DEMONSTRATION AND SEMIQUANTITATIVE DETERMINATION OF COMPLEXES BETWEEN VARIOUS PROTEASES AND HUMAN ALPHA2-MACROGLOBULIN [J].

OHLSSON, K ;

SKUDE, G .

CLINICA CHIMICA ACTA, 1976, 66 (01) :1-7

[95]

OHLSSON K, 1974, BAYER S, V5, P96

[96]

PLOW EF, 1981, BLOOD, V58, P1069

[97]

QUIGLEY JP, 1983, ANN NY ACAD SCI

[98] BIOLOGICAL SIGNIFICANCE OF SPECIFIC INTERACTION BETWEEN FIBRIN, PLASMINOGEN AND ANTIPLASMIN [J].

RAKOCZI, I ;

WIMAN, B ;

COLLEN, D .

BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 540 (02) :295-300

[99] INHIBITION OF PLASMIN PLASMA KALLIKREIN PLASMA PERMEABILITY FACTOR AND C'1R SUBCOMPONENT OF FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR [J].

RATNOFF, OD ;

PENSKY, J ;

OGSTON, D ;

NAFF, GB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (02) :315-&

[100]

RIJKEN DC, 1983, J LAB CLIN MED, V101, P274

← 5 6 7 8 9 10 11 12 13 14 →